Lamotrigin Actavis

Lamotrigine, the active ingredient in Lamotrigin Actavis, is an anticonvulsant presented as an oral tablet for oral use. It treats epilepsy and bipolar disorder in adults and children as prescribed.

GNH USA supplies Lamotrigin Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigin Actavis is an anticonvulsant used in the management of seizure disorders and mood stabilization.

Epilepsy: reduces the frequency and severity of seizures. Bipolar disorder: helps maintain mood stability and prevents depressive episodes. Generalized seizures: controls tonic‑clonic seizure activity.

Lamotrigin Actavis may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe blood dyscrasias (e.g., agranulocytosis) - Suicidal thoughts or behavior

Before initiating therapy, consider the following safety measures.

Monitor blood counts: regular laboratory testing is advised. Adjust dose in hepatic impairment: reduce dosage as needed. Avoid abrupt discontinuation: taper gradually to prevent seizure recurrence. Use caution in pregnancy: risk–benefit assessment required. Store at ambient temperature: keep in the original pack, protect from moisture.

Lamotrigin Actavis can interact with several medicines; awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma levels. - Carbamazepine: significantly reduces lamotrigine concentrations. - Oral contraceptives: may raise lamotrigine levels.

Moderate Interactions (Monitor Closely): - Phenobarbital: lowers lamotrigine levels. - Rifampin: induces metabolism, decreasing lamotrigine exposure. - Sertraline: may modestly increase lamotrigine concentrations.